Related Experiment Video
Updated: Jun 21, 2026

Watershed Planning within a Quantitative Scenario Analysis Framework
Published on: July 24, 2016
Regulatory approach on environmental risk assessment. Risk management recommendations, reasonable and prudent
Maria Leonor Meisel1, Maria do Céu Costa, Angelina Pena
1INFARMED, I.P., National Authority of Medicines and Health Products, 1749-004, Lisbon, Portugal. leonor.meisel@infarmed.pt
Abstract:
Current knowledge shows that residues of human medicinal products at trace quantities are widespread in aquatic systems. The sewage treatment plants are pointed out as the major source discharge of these compounds on the environment. In this context, it has been worldwide recognised that the environmental impact of medicinal products have to be evaluated, according to recent EU legislation and regulatory guidance. The strategy of the global risk assessment includes primarily a pre-screening based on the estimation of exposure concentrations of drugs in the wastewater. The present paper addresses the decision-maker frontier of the ecologically relevant endpoints. Risk management recommendation and reasonable and prudent alternatives are discussed to minimise the possible environmental impact.
More Related Videos
08:00Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
Published on: December 4, 2016
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Regulation
Relative Risk
Hazard Analysis and Critical Control Points (HACCP)
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions